Literature DB >> 33670452

Pediatric Primary Hepatic Tumors: Diagnostic Considerations.

Bryony Lucas1, Sanjita Ravishankar2, Irina Pateva3.   

Abstract

The liver is the third most common site of abdominal tumors in children. This review article aims to summarize current evidence surrounding identification and diagnosis of primary hepatic tumors in the pediatric population based upon clinical presentation, epidemiology, and risk factors as well as classical imaging, histopathological, and molecular diagnostic findings. Readers will be able to recognize the features and distinguish between benign and malignant hepatic tumors within different age groups.

Entities:  

Keywords:  angiosarcoma; focal nodular hyperplasia; hepatic adenoma; hepatoblastoma; hepatocellular carcinoma; infantile hepatic hemangioma; liver tumor; malignant rhabdoid tumor; mesenchymal hamartoma; pediatric; undifferentiated embryonal sarcoma

Year:  2021        PMID: 33670452     DOI: 10.3390/diagnostics11020333

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  4 in total

1.  Hepatic hemangiomas in childhood: the spectrum of radiologic findings. A pictorial essay.

Authors:  Francesco Esposito; Divina D'Auria; Dolores Ferrara; Pasquale Esposito; Giovanni Gaglione; Massimo Zeccolini; Paolo Tomà
Journal:  J Ultrasound       Date:  2022-09-07

2.  Competitive risk analysis of the therapeutic value of liver transplantation for liver cancer in children: A population-based study.

Authors:  Huiwu Xing; Chenyu Yang; Bingqian Tan; Mingman Zhang
Journal:  Front Surg       Date:  2022-08-31

Review 3.  Surgical Pathology Diagnostic Pitfalls of Hepatoblastoma.

Authors:  Finn Morgan Auld; Consolato M Sergi
Journal:  Int J Surg Pathol       Date:  2022-01-20       Impact factor: 1.358

Review 4.  Emerging Role and Mechanism of circRNAs in Pediatric Malignant Solid Tumors.

Authors:  Qiyang Shen; Xingyu Liu; Wei Li; Xu Zhao; Tao Li; Kai Zhou; Jianfeng Zhou
Journal:  Front Genet       Date:  2022-01-18       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.